Letter

Strategies for reducing coronary risk factors in primary care

BMJ 1995; 311 doi: 10.1136/bmj.311.6999.263a (Published 22 July 1995)
Cite this as: BMJ 1995;311:263.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. A S Wierzbicki,
  2. T M Reynolds
  1. Senior lecturer in chemical pathology United Medical and Dental Schools of Guy's and St Thomas's Hospitals, St Thomas' Hospital, London SE1 7EH
  2. Consultant chemical pathologist Burton Hospitals, Burton on Trent, Staffordshire DE13 0RB

    EDITOR,--K Field and colleagues claim to have evaluated the cost effectiveness of intervention protocols in primary care to reduce cardiovascular disease.1 They examined the costs of treatment with cholesterol lowering drugs (pounds sterling235/year) and ignored the cost of antihypertensive treatment (pounds sterling180-260/year). The costs of medical treatment for both conditions, including dietary modification of obesity and salt intake in hypertension, were roughly equivalent. Rates of therapeutically important severe hypertension (4.4%; 115/2607) and hyperlipidaemia (4.1%; 107/2607) are similar,2 and some patients need treatment for both …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular